Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease

Neurobiology of Aging

Volumn 26, Issue 6, 2005, Pages 891-898

  Brück, Anna ^a   Aalto, Sargo ^a   Nurmi, Elina ^a   Bergman, Jörgen ^a   Rinne, Juha O ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

6 18F fluoro L dopa; Attention; Cognition; Frontal lobe functions; Parkinson's disease; PET

Indexed keywords

6 FLUORODOPA F 18; TRACER; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; FLUORODOPA F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; ATTENTION; BRAIN CORTEX; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DRUG UPTAKE; FEMALE; FRONTAL CORTEX; FRONTAL LOBE; HUMAN; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PARAMETRIC TEST; PARKINSON DISEASE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESPONSE TIME; STATISTICAL PARAMETRIC MAPPING; AGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HOSPITALIZATION; METABOLISM; MIDDLE AGED; SCINTISCANNING; STATISTICS; TISSUE DISTRIBUTION;

AGING; CEREBRAL CORTEX; COGNITION DISORDERS; DIHYDROXYPHENYLALANINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; STATISTICS; TISSUE DISTRIBUTION;

EID: 13844254136     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.07.014     Document Type: Article

References (50)

1. Y. Agid, F. Javoyagid, and M. Ruberg Biochemistry of neurotransmitters in Parkinson's disease C.D. Marsden S. Fahn Movement disorders 2 1987 Buttersworths & Co Cornwall 166 230
2. A.F.T. Arnsten, and P.S. Goldman-Rakic Noise stress impairs prefrontal cortical cognitive function in monkeys - evidence for a hyperdopaminergic mechanism Arch Gen Psychiatry 55 1998 362 368
3. J. Bergman, M. Haaparanta, P. Lehikoinen, and O. Solin Electrophilic synthesis of 6-[18F]fluoro-l-dopa, starting from aqueous [18F]-fluoride J Label Compd Radiophram 35 1994 476 477
4. F.P. Bowen Behavioral alterations in patients with basal ganglia lesions Res Public Assoc Res Nerv Ment Dis 55 1976 169 177
5. D.J. Brooks, E.P. Salmon, C.J. Mathias, N. Quinn, K.L. Leenders, and R. Bannister The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinsons disease Stud Pet Brain 113 1990 1539 1552
6. E. Broussolle, C. Dentresangle, P. Landais, L. Garcia-Larrea, P. Pollak, and B. Croisile The relation of putamen and caudate nucleus F-18-dopa uptake to motor and cognitive performances in Parkinson's disease J Neurol Sci 166 1999 141 151
7. A. Bruck, R. Portin, A. Lindell, A. Laihinen, J. Bergman, and M. Haaparanta Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus Neurosci Lett 311 2001 81 84
8. R. Cabeza, and L. Nyberg Imaging cognition II: an empirical review of 275 PET and fMRI studies J Cogn Neurosci 12 2000 1 47
9. R. Cools, R.A. Barker, B.J. Sahakian, and T.W. Robbins l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease Neuropsychologia 41 2003 1431 1441
10. R. Cools, R. Swainson, A.M. Owen, and T.W. Robbins Cognitive dysfunction in non-demented Parkinson's disease E.Ch. Wolters Ph. Scheltens H.W. Berendse Mental dysfunction in Parkinson's disease 1999 Academic Pharmaceutical Productions BV Utrecht 142 164
11. B. Dubois, and B. Pillon Cognitive deficits in Parkinson's disease J Neurol 244 1997 2 8
12. K. Dujardin, J.F. Degreef, P. Rogelet, L. Defebvre, and A. Destee Impairment of the supervisory attentional system in early untreated patients with Parkinson's disease J Neurol 246 1999 783 788
13. J. Duncan, and A.M. Owen Common regions of the human frontal lobe recruited by diverse cognitive demands Trends Neurosci 23 2000 475 483
14. B. Faw Pre-frontal executive committee for perception, working memory, attention, long-term memory, motor control, and thinking: a tutorial review Conscious Cogn 12 2003 83 139
15. K.J. Friston, A.P. Holmes, K.J. Worsley, J.B. Poline, C.D. Frith, and R.S.J. Frackowiak Statistical parametric maps in functional imaging. A general approach Hum Brain Mapp 2 1995 189 210
16. A.M. Gotham, R.G. Brown, and C.D. Marsden Frontal cognitive function in patients with Parkinsons-disease on and off levodopa Brain 111 1988 299 321
17. R.P. Hart, J.B. Wade, V.P. Calabrese, and C.C. Colenda Vigilance performance in Parkinson's disease and depression J Clin Exp Neuropsychol 20 1998 111 117
18. V.A. Holthoff-Detto, J. Kessler, K. Herholz, H. Bonner, U. Pietrzyk, and M. Wurker Functional effects of striatal dysfunction in Parkinson disease Arch Neurol 54 1997 145 150
19. O. Hornykiewicz Compensatory biochemical changes at the striatal dopamine synapse in Parkinson's disease - limitation of l-DOPA therapy Adv Neurol 24 1979 275 281
20. A.J. Hughes, S.E. Daniel, S. Blankson, and A.J. Lees A clinicopathological study of 100 cases of Parkinsons-disease Arch Neurol 50 1993 140 148
21. K. Ito, P.K. Morrish, J.S. Rakshi, T. Uema, J. Ashburner, and D.L. Bailey Statistical parametric mapping with F-18-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease J Neurol Neurosurg Psychiatry 66 1999 754 758
22. K. Ito, A. Nagano-Saito, T. Kato, Y. Arahata, A. Nakamura, and Y. Kawasumi Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[F-18]fluoro-l-dopa PET study Brain 125 2002 1358 1365
23. F. Javoyagid, B. Scatton, M. Ruberg, R. Lheureux, P. Cervera, and R. Raisman Distribution of monoaminergic, cholinergic, and gabaergic markers in the human cerebral-cortex Neuroscience 29 1989 251 259
24. V. Kaasinen, K. Nagren, J. Hietala, V. Oikonen, H. Vilkman, and L. Farde Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease Neurology 54 2000 1482 1487
25. V. Kaasinen, E. Nurmi, A. Bruck, J. Bergman, O. Solin, and J.O. Rinne Increased frontal [F-18]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex Brain 124 2001 1125 1130
26. L. Kerenyi, G.A. Ricaurte, D.J. Schretlen, U. McCann, J. Varga, and W.B. Mathews Positron emission tomography of striatal serotonin transporters in Parkinson disease Arch Neurol 60 2003 1223 1229
27. P. Kujala, R. Portin, A. Revonsuo, and J. Ruutiainen Attention related performance in 2 cognitively different subgroups of patients with multiple-sclerosis J Neurol Neurosurg Psychiatry 59 1995 77 82
28. J. Kulisevsky Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease Drugs Aging 16 2000 365 379
29. J.L. Lancaster, M.G. Woldorff, L.M. Parsons, M. Liotti, E.S. Freitas, and L. Rainey Automated Talairach Atlas labels for functional brain mapping Hum Brain Mapp 10 2000 120 131
30. K.W. Lange, T.W. Robbins, C.D. Marsden, M. James, A.M. Owen, and G.M. Paul l-Dopa withdrawal in Parkinsons-disease selectively impairs cognitive performance in tests sensitive to frontal-lobe dysfunction Psychopharmacology 107 1992 394 404
31. R.M. Marie, L. Barre, B. Dupuy, F. Viader, G. Defer, and J.C. Baron Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease Neurosci Lett 260 1999 77 80
32. S. McGowan, A.D. Lawrence, T. Sales, D. Quested, and P. Grasby Presynaptic dopaminergic dysfunction in schizophrenia - a positron emission tomographic [F-18]fluorodopa study Arch Gen Psychiatry 61 2004 134 142
33. J.H. Meyer, R.N. Gunn, R. Myers, and P.M. Grasby Assessment of spatial normalization of PET ligand images using ligand-specific templates Neuroimage 9 1999 545 553
34. E. Mohr, G. Fabbrini, S. Ruggieri, P. Fedio, and T.N. Chase Cognitive concomitants of dopamine system stimulation in Parkinsonian-patients J Neurol Neurosurg Psychiatry 50 1987 1192 1196
35. P.K. Morrish, G.W. Sawle, and D.J. Brooks Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease Brain 119 1996 2097 2103
36. A.S. Nagano, K. Ito, T. Kato, Y. Arahata, T. Kachi, and K. Hatano Extrastriatal mean regional uptake of fluorine-18-FDOPA in the normal aged brain - an approach using MRI-aided spatial normalization Neuroimage 11 2000 760 766
37. M. Namavari, A. Bishop, N. Satyamurthy, G. Bida, and J.R. Barrio Regioselective radiofluorodestannylation with [F-18] F2 and [F-18] Ch3Coof - a high-yield synthesis of 6-[F-18]fluoro-l-dopa Appl Radiat Isot 43 1992 989 996
38. A. Nieoullon Dopamine and the regulation of cognition and attention Prog Neurobiol 67 2002 53 83
39. E. Nurmi, H.M. Ruottinen, J. Bergman, M. Haaparanta, O. Solin, and P. Sonninen Rate of progression in Parkinson's disease: a 6-[F-18]fluoro-l-dopa PET study Mov Disord 16 2001 608 615
40. A.M. Owen, J. Doyon, A. Dagher, A. Sadikot, and A.C. Evans Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions Brain 121 Pt 5 1998 949 965
41. A.M. Owen, M. James, N. Leigh, B.A. Summers, C.D. Marsden, and N. Quinn Fronto-striatal cognitive deficits at different stages of Parkinson's disease Brain 115 1992 1727 1751
42. C.S. Patlak, and R.G. Blasberg Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data - generalizations J Cereb Blood Flow Metab 5 1985 584 590
43. R. Portin, and U.K. Rinne Neuropsychological responses of parkinsonian patients to longterm levodopa treatment U.K. Rinne M. Klingler Parkinson's disease - current progress, problems and management 1980 Elsevier Biomedical Press Amsterdam 271 304
44. J.S. Rakshi, T. Uema, K. Ito, D.L. Bailey, P.K. Morrish, and J. Ashburner Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease - a 3D [F-18]dopa-PET study Brain 122 1999 1637 1650
45. A. Revonsuo, R. Portin, L. Koivikko, J.O. Rinne, and U.K. Rinne Slowing of information-processing in Parkinsons-disease Brain Cogn 21 1993 87 110
46. J.O. Rinne, R. Portin, H. Ruottinen, E. Nurmi, J. Bergman, and M. Haaparanta Cognitive impairment and the brain dopaminergic system in Parkinson disease - [F-18]fluorodopa positron emission tomographic study Arch Neurol 57 2000 470 475
47. T.W. Robbins Chemical neuromodulation of frontal-executive functions in humans and other animals Exp Brain Res 133 2000 130 138
48. K. Shannak, A. Rajput, B. Rozdilsky, S. Kish, J. Gilbert, and O. Hornykiewicz Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus - observations in Parkinsons-disease and normal subjects Brain Res 639 1994 33 41
49. J.R. Stroop Studies of interference in serial verbal reactions J Exp Psychol 18 1935 643 662
50. F. Talairach, and P. Tournoux Co-planar stereotaxic atlas of the human brain 1988 New York Thieme